See below for Upcoming, Current and Past events, but note: not all entries have been made, as this page is currently under construction.
Please check back soon for the latest upcoming events, speaking engagements, conference appearances, and media features featuring Gregg A. Jackson.
UPCOMING EVENTS
Opal Group Family Office and Private Investor Event
Newport, RI July 2026
A quick shout out to all of my Family Office, Investors, Angel and Venture Capital friends and colleagues!
Excited to be onsite today and this week in Newport, RI for the Opal Group’s Family Office & Private Wealth Management Forum
<-- CLICK PHOTO TO VIEW EVENT AND POST
Add a Title
Add paragraph text. Click “Edit Text” to update the font, size and more.
To change and reuse text themes, go to Site Styles.
CURRENT / IN-PROGRESS EVENTS
Add a Title
Add paragraph text. Click “Edit Text” to update the font, size and more.
To change and reuse text themes, go to Site Styles.
Add a Title
Add paragraph text. Click “Edit Text” to update the font, size and more.
To change and reuse text themes, go to Site Styles.
PAST EVENTS
Commercialization Playbook: Accelerating Revenue, Investor Readiness & Enterprise Value
Keynote Speaker | Summer 2026 Digital Venture Forum
Why do great technologies and promising companies still struggle to achieve commercial traction and scale?
In this keynote workshop, Gregg A. Jackson draws on 35+ years of commercialization leadership, $6B+ in product launches, $33B+ in strategic transactions and four exits to share practical, real-world strategies for accelerating commercialization, reducing execution risk, strengthening investor readiness and building enterprise value.
Particularly relevant for growth-stage healthcare companies, venture capital and private equity firms, family offices, strategic investors, accelerators and portfolio leaders seeking to help promising companies commercialize and scale.
Gregg also introduces SCORE2SCALE™, his framework for identifying and addressing commercialization gaps that can constrain growth, investor readiness and enterprise value.
“Technology gets you in the room. Commercial traction determines what happens next.”
▶ WATCH THE KEYNOTE & COMMERCIALIZATION WORKSHOP
Continue the conversation on LinkedIn + access the Commercialization Executive Guide →
Gregg works with growth-stage healthcare companies, investors and portfolio leaders on commercialization strategy, strategic partnerships, growth execution, investor readiness, and Fractional COO / executive leadership.
From Innovation to Adoption: Building Healthcare Companies That Win
Opening Keynote | Convergence Health Summit NYC | Wall Street, NYC | July 2026
“Don’t surround yourself with people who simply say ‘No.’
Surround yourself with people who say, ‘Let’s figure it out.’”
In this 8-minute opening keynote, Gregg A. Jackson shares a motivational message for founders, entrepreneurs, investors, family offices, venture studios, and portfolio leaders working to solve important unmet needs across MedTech, NeuroTech, Digital Health, AI, and the Life Sciences.
Drawing on 35+ years of commercialization experience, $6B+ in product launches and $33B+ in strategic transactions, Gregg explores the persistence, commercialization discipline, investor readiness, and “super operators” required to turn breakthrough innovation into adoption, scalable growth, and enterprise value.
<-- Click on the photo to the left to WATCH THE 8-MINUTE KEYNOTE
The Neurotech Opportunity - Why the Most Overlooked Category in Venture is Also the Most Universal
Opening Keynote | Convergence Health Summit NYC | Wall Street, NYC | July 2026
“Don’t surround yourself with people who simply say ‘No.’
Surround yourself with people who say, ‘Let’s figure it out.’”
In this 8-minute opening keynote, Gregg A. Jackson shares a motivational message for founders, entrepreneurs, investors, family offices, venture studios, and portfolio leaders working to solve important unmet needs across MedTech, NeuroTech, Digital Health, AI, and the Life Sciences.
Drawing on 35+ years of commercialization experience, $6B+ in product launches and $33B+ in strategic transactions, Gregg explores the persistence, commercialization discipline, investor readiness, and “super operators” required to turn breakthrough innovation into adoption, scalable growth, and enterprise value.
<-- Click on the photo to the left to WATCH THE 8-MINUTE KEYNOTE
BIOFUTURE 2025: CONNECTING HEALTHCARE INNOVATION, CAPITAL & COMMERCIALIZATION
Healthcare Investor & Commercialization Executive | Cure, New York City | October 2025
I was pleased to participate in BioFuture 2025, which brought together leaders from biopharma, MedTech, digital health, TechBio, artificial intelligence and the investment community to explore what is shaping the next era of healthcare.
The conference featured candid discussions among entrepreneurs, investors, strategic partners and industry leaders on emerging technologies, healthcare financing, policy, neuroscience, diagnostics and the changing environment for building and funding innovative companies.
For me, these conversations reinforced a theme that runs through much of my work: great innovation is only the beginning. Creating meaningful clinical impact and enterprise value also requires intentional commercialization, experienced leadership, strategic partnerships, investor readiness and disciplined execution.
BioFuture provided another valuable opportunity to connect with healthcare founders, investors and strategic leaders working to move promising innovations from technology and clinical validation toward commercial traction and scalable growth.
Interested in discussing commercialization strategy, portfolio company support, strategic partnerships or fractional operating leadership?
Let’s connect.
<-- CLICK PHOTO TO VIEW EVENT POST
© 2026 Gregg A. Jackson Family Office. All rights reserved.
Information presented on this website is for general informational purposes only and does not constitute an offer, solicitation, or investment advice.